These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9413804)

  • 41. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
    Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effects of a low dose dopamine infusion on prolactin secretion in normal and hyperprolactinemic subjects.
    Serri O; Kuchel O; Buu NT; Somma M
    J Clin Endocrinol Metab; 1983 Feb; 56(2):255-9. PubMed ID: 6822635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of the GABAergic drug, sodium valproate, on the prolactin release evoked by pharmacological stimuli in normal women.
    Melis GB; Fruzzetti F; Paoletti AM; Mais V; Beneventi F; Trimarchi G; Fioretti P
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):245-52. PubMed ID: 6426828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia].
    Tkachenko NN; Potin VV; Beskrovnyĭ SV; Nosova LG
    Probl Endokrinol (Mosk); 1990; 36(2):35-40. PubMed ID: 2114023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central opioid receptor activity in patients affected by puerperal, idiopathic and tumoral hyperprolactinemia.
    De Leo V; Petraglia F; Sardelli S; De Leo M; Genazzani AR; D'Antona N
    Gynecol Obstet Invest; 1985; 19(3):160-5. PubMed ID: 2991091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prolactin after baclofen in healthy subjects and prolactinoma patients].
    Morosini PP; Carletti P; Sarzani R; Ferretti GF; Marchesi GF; Nardi B
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):33-8. PubMed ID: 2983744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells.
    Ben-Shlomo A; Miklovsky I; Ren SG; Yong WH; Heaney AP; Culler MD; Melmed S
    J Clin Endocrinol Metab; 2003 Feb; 88(2):858-63. PubMed ID: 12574225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
    Anderson PW; Malarkey WB; Salk J; Kletsky OA; Hsueh WA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):518-22. PubMed ID: 2503532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
    Schlechte JA; Sherman BM; Chapler FK; VanGilder J
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
    Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
    Arafah BM; Nekl KE; Gold RS; Selman WR
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
    Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
    J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
    Ferrari C; Crosignani PG; Caldara R; Picciotti MC; Malinverni A; Barattini B; Rampini P; Telloli P
    J Clin Endocrinol Metab; 1980 Jan; 50(1):23-6. PubMed ID: 7188615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV; Shyr SW; Grosvenor CE; Crowley WR
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of tissue responsiveness to angiotensin-II in hyperprolactinemic subjects.
    Arafah BM; Gordon NH; Salazar R; Douglas JG
    J Clin Endocrinol Metab; 1990 Jul; 71(1):60-6. PubMed ID: 2370301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased androgen secretion in patients with prolactinomas: the impact of altered HPA function.
    Moria Y; Kortbawi R; El-Asmar N; Arafah BM
    Pituitary; 2019 Apr; 22(2):170-178. PubMed ID: 30798438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of hyperprolactinemia on ornithine decarboxylase activity and polyamine levels in seminal vesicles of genetically prolactin-deficient adult dwarf mice.
    Gonzalez SI; Chandrashekar V; Shire JG; Lüthy IA; Bartke A; Calandra RS
    Biol Reprod; 1991 Feb; 44(2):321-6. PubMed ID: 2009332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in the effect of gamma-aminobutyric acid on prolactin secretion during sexual maturation in female rats.
    Moguilevsky JA; Carbone S; Szwarcfarb B
    Endocrinology; 1992 Jul; 131(1):458-62. PubMed ID: 1319326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas.
    Iannotta F; Fachinetti P; Fachinetti A; Pinotti G; Usellini L
    J Endocrinol Invest; 1983 Oct; 6(5):353-8. PubMed ID: 6420458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinicopathology, clonality, and hormone production profile of prolactinoma].
    Ma WB; Ikeda H; Yoshimoto T
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1382-7. PubMed ID: 16029648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.